Dose Finding Study in Patients With Mild to Moderate Persistent Asthma: A Parallel Group, Randomised, Placebo Controlled, Double Blind Assessment of Oral Oc000459 Dosed At Three Dose Schedules for Twelve Weeks Finding Study In Patients With Mild To Moderate Persistent Asthma.
Phase of Trial: Phase II
Latest Information Update: 27 May 2014
At a glance
- Drugs OC 459 (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 23 Oct 2012 Planned number of patients changed from 480 to 900 as reported by European Clinical Trials Database record
- 01 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.